These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27230403)

  • 1. Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic study.
    Pandey SK; Biswas S; Gunjan S; Chauhan BS; Singh SK; Srivastava K; Singh S; Batra S; Tripathi R
    Parasitology; 2016 Sep; 143(11):1421-32. PubMed ID: 27230403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split dosing of artemisinins does not improve antimalarial therapeutic efficacy.
    White NJ; Watson J; Ashley EA
    Sci Rep; 2017 Sep; 7(1):12132. PubMed ID: 28935919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Sato A; Hiramoto A; Morita M; Matsumoto M; Komich Y; Nakase Y; Tanigawa N; Hiraoka O; Hiramoto K; Hayatsu H; Higaki K; Kawai S; Masuyama A; Nojima M; Wataya Y; Kim HS
    Parasitol Int; 2011 Sep; 60(3):270-3. PubMed ID: 21501696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
    Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
    Wilairat P; Kümpornsin K; Chookajorn T
    Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.
    Wongsrichanalai C; Sibley CH
    Clin Microbiol Infect; 2013 Oct; 19(10):908-16. PubMed ID: 24033691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
    Hastings IM; Kay K; Hodel EM
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6428-36. PubMed ID: 26239987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria.
    Na-Bangchang K; Tipwangso P; Thanavibul A; Tan-ariya P; Suprakob K; Kanda T; Karbwang J
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):19-23. PubMed ID: 9031394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India.
    Das S; Manna S; Saha B; Hati AK; Roy S
    Clin Infect Dis; 2019 Sep; 69(7):1144-1152. PubMed ID: 30535043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anti-malarial combinations and their toxicity.
    Angus B
    Expert Rev Clin Pharmacol; 2014 May; 7(3):299-316. PubMed ID: 24716844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.